Activation of p53 for the treatment of cancer

Journal of Cellular Biochemistry

Volumn 107, Issue 4, 2009, Pages 567-568

  Chen, Jiezhong ^a   Huang, Xu Feng ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLIN DEPENDENT KINASE; CYCLINE; DNA POLYMERASE; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN P21; PROTEIN P53; ROSCOVITINE; SERINE;

APOPTOSIS; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CYTOTOXICITY; ENZYME ACTIVITY; GARLIC; HELA CELL; HUMAN; MUSHROOM; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; HUMANS; NEOPLASMS; PHOSPHORYLATION; PURINES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67650066352     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22187     Document Type: Short Survey

References (12)

1. Chen J, Seviour R. 2007. Medicinal importance of fungal beta-(1->3), (1->6)-glucans. Mycol Res 111:635-652. (Pubitemid 47082471)
2. Dey A, Tergaonkar V, Lane DP. 2008. Double-edged swords as cancer therapeutics: Simultaneously targeting p53 and NF-kappaB pathways. Nat Rev Drug Discov 7:1031-1040.
3. Jedinak A, Sliva D. 2008. Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway. Int J Oncol 33:1307-1313.
4. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR. 1993. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90:3988-3992. (Pubitemid 23134151)
5. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810. (Pubitemid 24359290)
6. Peng CC, Chen KC, Peng RY, Chyau CC, Su CH, Hsieh-Li HM. 2007. Antrodia camphorata extract induces replicative senescence in superficial TCC, and inhibits the absolute migration capability in invasive bladder carcinoma cells. J Ethnopharmacol 109:93-103. (Pubitemid 44920191)
7. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. 2007. TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes. Oncogene 26:2157-2165. (Pubitemid 46536647)
8. Song JD, Lee SK, Kim KM, Park SE, Park SJ, Kim KH, Ahn SC, Park YC. 2009. Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT-116 colon cancer cells. J Biochem Mol Toxicol 23:71-79.
9. Soussi T, Wiman KG. 2007. Shaping genetic alterations in human cancer: The p53 mutation paradigm. Cancer Cell 12:303-312. (Pubitemid 47539312)
10. Vazquez A, Bond EE, Levine AJ, Bond GL. 2008. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 7:979-987.
11. Warbrick E, Lane DP, Glover DM, Cox LS. 1997. Homologous regions of Fen1 and p21Cip1 compete for binding to the same site on PCNA: A potential mechanism to co-ordinate DNA replication and repair. Oncogene 14:2313-2321. (Pubitemid 27260723)
12. Wesierska-Gadek J, Wandl S, Kramer MP, Pickem C, Krystof V, Hajek SB. 2008. Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS(3) cervix carcinoma cells. J Cell Biochem 105:1161-1171.